1
|
Ostrom QT, Gittleman H, Fulop J, Liu M,
Blanda R, Kromer C, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS Statistical Report: Primary brain and central nervous system
tumors diagnosed in the United States in 2008–2012. Neuro Oncol. 17
Suppl 4:iv1–iv62. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Duchartre Y, Kim YM and Kahn M: The Wnt
signaling pathway in cancer. Crit Rev Oncol Hematol. 99:141–149.
2016. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chen N and Karantza V: Autophagy as a
therapeutic target in cancer. Cancer Biol Ther. 11:157–168. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Kaza N, Kohli L and Roth KA: Autophagy in
brain tumors: A new target for therapeutic intervention. Brain
Pathol. 22:89–98. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao
X, Guo X, Xu S, Li T, Shao Q, et al: A novel tumor-promoting
mechanism of IL6 and the therapeutic efficacy of tocilizumab:
Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma
via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 12:1129–1152.
2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chen W, Xia T, Wang D, Huang B, Zhao P,
Wang J, Qu X and Li X: Human astrocytes secrete IL-6 to promote
glioma migration and invasion through upregulation of cytomembrane
MMP14. Oncotarget. 7:62425–62438. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kikuchi A, Yamamoto H and Kishida S:
Multiplicity of the interactions of Wnt proteins and their
receptors. Cell Signal. 19:659–671. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lerner UH and Ohlsson C: The WNT system:
Background and its role in bone. J Intern Med. 277:630–649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Prakash S and Swaminathan U: β catenin in
health: A review. J Oral Maxillofac Pathol. 19:230–238. 2015.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Bielen H and Houart C: The Wnt cries many:
Wnt regulation of neurogenesis through tissue patterning,
proliferation, and asymmetric cell division. Dev Neurobiol.
74:772–780. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Nusse R: Wnt signaling and stem cell
control. Cell Res. 18:523–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
12
|
Adachi K, Mirzadeh Z, Sakaguchi M,
Yamashita T, Nikolcheva T, Gotoh Y, Peltz G, Gong L, Kawase T,
Alvarez-Buylla A, et al: Beta-catenin signaling promotes
proliferation of progenitor cells in the adult mouse subventricular
zone. Stem Cells. 25:2827–2836. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Van Camp JK, Beckers S, Zegers D and Van
Hul W: Wnt signaling and the control of human stem cell fate. Stem
Cell Rev. 10:207–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
14
|
Cerpa W, Godoy JA, Alfaro I, Farías GG,
Metcalfe MJ, Fuentealba R, Bonansco C and Inestrosa NC: Wnt-7a
modulates the synaptic vesicle cycle and synaptic transmission in
hippocampal neurons. J Biol Chem. 283:5918–5927. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Maguschak KA and Ressler KJ: A role for
WNT/β-catenin signaling in the neural mechanisms of behavior. J
Neuroimmune Pharmacol. 7:763–773. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Boitard M, Bocchi R, Egervari K, Petrenko
V, Viale B, Gremaud S, Zgraggen E, Salmon P and Kiss JZ: Wnt
signaling regulates multipolar-to-bipolar transition of migrating
neurons in the cerebral cortex. Cell Rep. 10:1349–1361. 2015.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Lee SC, Kim OH, Lee SK and Kim SJ: IWR-1
inhibits epithelial-mesenchymal transition of colorectal cancer
cells through suppressing Wnt/β-catenin signaling as well as
survivin expression. Oncotarget. 6:27146–27159. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Liu WT, Huang CY, Lu IC and Gean PW:
Inhibition of glioma growth by minocycline is mediated through
endoplasmic reticulum stress-induced apoptosis and autophagic cell
death. Neuro Oncol. 15:1127–1141. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Al Dhaheri Y, Attoub S, Ramadan G, Arafat
K, Bajbouj K, Karuvantevida N, AbuQamar S, Eid A and Iratni R:
Carnosol induces ROS-mediated beclin1-independent autophagy and
apoptosis in triple negative breast cancer. PLoS One.
9:e1096302014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wu S, Sun C, Tian D, Li Y, Gao X, He S and
Li T: Expression and clinical significances of Beclin1, LC3 and
mTOR in colorectal cancer. Int J Clin Exp Pathol. 8:3882–3891.
2015.PubMed/NCBI
|
21
|
Suh Y, Afaq F, Khan N, Johnson JJ, Khusro
FH and Mukhtar H: Fisetin induces autophagic cell death through
suppression of mTOR signaling pathway in prostate cancer cells.
Carcinogenesis. 31:1424–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hamed HA, Yacoub A, Park MA, Eulitt P,
Sarkar D, Dimitrie IP, Chen CS, Grant S, Curiel DT, Fisher PB, et
al: OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress
and autophagy and by decreasing expression of mitochondrial
protective proteins. Cancer Biol Ther. 9:526–536. 2010. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tan X, Carretero J, Chen Z, Zhang J, Wang
Y, Chen J, Li X, Ye H, Tang C, Cheng X, et al: Loss of p53
attenuates the contribution of IL-6 deletion on suppressed tumor
progression and extended survival in Kras-driven murine lung
cancer. PLoS One. 8:e808852013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Liu F, Zhang W, Yang F, Feng T, Zhou M, Yu
Y, Yu X, Zhao W, Yi F, Tang W, et al: Interleukin-6-stimulated
progranulin expression contributes to the malignancy of
hepatocellular carcinoma cells by activating mTOR signaling. Sci
Rep. 6:212602016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Banday MZ, Balkhi HM, Hamid Z, Sameer AS,
Chowdri NA and Haq E: Tumor necrosis factor-α (TNF-α)-308G/A
promoter polymorphism in colorectal cancer in ethnic Kashmiri
population - a case control study in a detailed perspective. Meta
Gene. 9:128–136. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shan Y, He X, Song W, Han D, Niu J and
Wang J: Role of IL-6 in the invasiveness and prognosis of glioma.
Int J Clin Exp Med. 8:9114–9120. 2015.PubMed/NCBI
|
27
|
Zhao X, Laver T, Hong SW, Twitty GB Jr,
Devos A, Devos M, Benveniste EN and Nozell SE: An NF-κB p65-cIAP2
link is necessary for mediating apoptotic resistance to TNF-α in
gliomas. J Neurooncol. 102:367–381. 2011. View Article : Google Scholar : PubMed/NCBI
|